Skip to main content
JDRS · Open access journal
Joint Diseases and
Related Surgery
Online manuscript submissionSubmit a manuscript e-ISSN 2687-4792

Original Article · Open access

Chondromyxoid fibroma: A retrospective evaluation of 31 cases

PDF Cite this article

Mustafa Onur Karaca

Department of Orthopedics and Traumatology, Ankara University Faculty of Medicine, Ankara, Türkiye

ORCID: 0000-0003-0783-510X

Mustafa Özyıldıran

Department of Orthopedics and Traumatology, Sandıklı State Hospital, Afyonkarahisar, Türkiye

ORCID: 0000-0002-2187-9267

Rauf Alizade

Department of Orthopedics and Traumatology, Ankara University Faculty of Medicine, Ankara, Türkiye

ORCID: 0009-0002-3185-3471

Kerem Başarır

Department of Orthopedics and Traumatology, Private Orthopedic Surgeon, Ankara, Türkiye

ORCID: 0000-0001-6247-8737

Hüseyin Yusuf Yıldız

Department of Orthopedics and Traumatology, Ankara University Faculty of Medicine, Ankara, Türkiye

ORCID: 0000-0002-7669-6206

Abstract

Objectives: This study aimed to review a 35-year experience with chondromyxoid fibroma at our institution.

Patients and methods: The study retrospectively analyzed the records of 31 consecutive patients (17 males, 14 females; mean age: 30.5±15.7 years; range, 6 to 63 years) with chondromyxoid fibroma who were treated between January 1988 and December 2021. The clinical and radiological characteristics of lesions, tumor volume, and recurrence rates were assessed using the tumor archive of the hospital.

Results: The mean follow-up duration was 65.9±42.0 months. Pelvis, proximal tibia, and distal femur were the most common sites of localization. The initial surgical treatment was performed on 27 patients at our clinic, while four patients were referred to the clinic after recurrence. The overall recurrence rate was 16.1%. Intralesional curettage was applied to 21 (77.8%) out of 27 patients. The cavity created after curettage was filled with bone graft (autograft or allograft) in 15 (55.5%) cases. Bone cement was applied in four (14.8%) cases. Resection was applied to five (18.5%) patients. In two (7.4%) cases, intralesional curettage alone was performed. One of these two patients experienced recurrence, resulting in a recurrence rate of 50% in this patient group. No recurrence was observed in other treatment groups.

Conclusion: Intralesional curettage and filling the defect with bone graft or cement were effective for local control in most cases. Curettage alone was associated with high recurrence rates.

Declarations

Ethics Committee Approval

The study protocol was approved by the Ankara University Faculty of Medicine Ethics Committee (date: 09.02.2022, no: İ01-55-22). The study was conducted in accordance with the principles of the Declaration of Helsinki.

Informed Consent

A written informed consent was obtained from the patients and/or parents of the patients.

Author Contributions

Idea/concept: M.O.K., K.B., H.Y.Y.; Design: M.O.K., M.Ö.; Data collection/processing: M.Ö., R.A.; Analysis/interpretation: M.Ö., R.A.; Literature review: M.Ö., R.A.; Drafting/writing: M.O.K., M.Ö.; Control and critical review: M.O.K., H.Y.Y.

Conflict of Interest

The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.

Financial Disclosure

The authors received no financial support for the research and/or authorship of this article.

Data Sharing Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

References

  1. Wu CT, Inwards CY, O’Laughlin S, Rock MG, Beabout JW, Unni KK. Chondromyxoid fibroma of bone: A clinicopathologic review of 278 cases. Hum Pathol 1998;29:438-46. DOI: 10.1016/s0046-8177(98)90058-2.
  2. Zillmer DA, Dorfman HD. Chondromyxoid fibroma of bone: Thirty-six cases with clinicopathologic correlation. Hum Pathol 1989;20:952-64. DOI: 10.1016/0046-8177(89)90267-0.
  3. Budny AM, Ismail A, Osher L. Chondromyxoid fibroma. J Foot Ankle Surg 2008;47:153-9. DOI: 10.1053/j.jfas.2007.08.013.
  4. De Mattos CB, Angsanuntsukh C, Arkader A, Dormans JP. Chondroblastoma and chondromyxoid fibroma. J Am Acad Orthop Surg 2013;21:225-33. DOI: 10.5435/JAAOS-21-04-225.
  5. Jaffe HL, Lichtenstein L. Chondromyxoid fibroma of bone; a distinctive benign tumor likely to be mistaken especially for chondrosarcoma. Arch Pathol (Chic) 1948;45:541-51.
  6. Bhamra JS, Al-Khateeb H, Dhinsa BS, Gikas PD, Tirabosco R, Pollock RC, et al. Chondromyxoid fibroma management: A single institution experience of 22 cases. World J Surg Oncol 2014;12:283. DOI: 10.1186/1477-7819-12-283.
  7. Desai SS, Jambhekar NA, Samanthray S, Merchant NH, Puri A, Agarwal M. Chondromyxoid fibromas: A study of 10 cases. J Surg Oncol. 2005 Jan 1;89(1):28-31. DOI: 10.1002/jso.20113.
  8. Baker AC, Rezeanu L, O'Laughlin S, Unni K, Klein MJ, Siegal GP. Juxtacortical chondromyxoid fibroma of bone: A unique variant: A case study of 20 patients. Am J Surg Pathol 2007;31:1662-8. DOI: 10.1097/PAS.0b013e31806772ec.
  9. Sharma H, Jane MJ, Reid R. Chondromyxoid fibroma of the foot and ankle: 40 years' Scottish bone tumour registry experience. Int Orthop 2006;30:205-9. DOI: 10.1007/s00264-005-0046-y.
  10. Armah HB, McGough RL, Goodman MA, Gollin SM, Surti U, Parwani AV, et al. Chondromyxoid fibroma of rib with a novel chromosomal translocation: A report of four additional cases at unusual sites. Diagn Pathol 2007;2:44. DOI: 10.1186/1746-1596-2-44.
  11. Yamaguchi T, Dorfman HD. Radiographic and histologic patterns of calcification in chondromyxoid fibroma. Skeletal Radiol 1998;27:559-64. DOI: 10.1007/s002560050437.
  12. Lersundi A, Mankin HJ, Mourikis A, Hornicek FJ. Chondromyxoid fibroma: A rarely encountered and puzzling tumor. Clin Orthop Relat Res 2005;439:171-5. DOI: 10.1097/01.blo.0000174685.62379.6a.
  13. Feldman JP, Goldwasser R, Mark S, Schwartz J, Orion I. A mathematical model for tumor volume evaluation using two-dimensions. Journal of Applied Quantitative Methods 2009;4:455-62.
  14. Mayr NA, Taoka T, Yuh WT, Denning LM, Zhen WK, Paulino AC, et al. Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2002;52:14-22. DOI: 10.1016/s0360-3016(01)01808-9.
  15. Singhal S, Gill M, Srivastava C, Gupta D, Kumar A, Kaushik A, et al. Simplifying tumor volume estimation from linear dimensions for intra-cranial lesions treated with stereotactic radiosurgery. J Med Phys 2020;45:199- 205. DOI: 10.4103/jmp.JMP_56_20.
  16. Yurtbay A, Coşkun HS, Çinka H, Erdoğan F, Büyükceran İ, Dabak N. The effect of adjuvant cryotherapy added to well-performed high-speed burr curettage on the long-term surgical outcomes of chondroblastoma cases. Jt Dis Relat Surg 2023;34:338-45. DOI: 10.52312/jdrs.2023.936.
  17. Wilson AJ, Kyriakos M, Ackerman LV. Chondromyxoid fibroma: Radiographic appearance in 38 cases and in a review of the literature. Radiology 1991;179:513-8. DOI: 10.1148/radiology.179.2.2014302.
  18. Sono T, Ware AD, McCarthy EF, James AW. Chondromyxoid fibroma of the pelvis: Institutional case series with a focus on distinctive features. Int J Surg Pathol 2019;27:352-9. DOI: 10.1177/1066896918820446.
  19. Wu KK. Chondromyxoid fibroma of the foot bones. J Foot Ankle Surg 1995;34:513-9. DOI: 10.1016/S1067-2516(09)80030-6.
  20. Roberts EJ, Meier MJ, Hild G, Masadeh S, Hardy M, Bakotic BW. Chondromyxoid fibroma of the calcaneus: Two case reports and literature review. J Foot Ankle Surg 2013;52:643-9. DOI: 10.1053/j.jfas.2013.02.014.
  21. Feldman F, Hecht HL, Johnston AD. Chondromyxoid fibroma of bone. Radiology 1970;94:249-60. DOI: 10.1148/94.2.249.
  22. Gherlinzoni F, Rock M, Picci P. Chondromyxoid fibroma. The experience at the Istituto Ortopedico Rizzoli. J Bone Joint Surg [Am] 1983;65:198-204. DOI: 10.2106/00004623-198365020-00008.
  23. Atik OŞ. Writing for Joint Diseases and Related Surgery (JDRS): There is something new and interesting in this article! Jt Dis Relat Surg 2023;34:533. DOI: 10.52312/jdrs.2023.57916.